(e) arising under a foreign exchange transaction or commodity derivatives for spot or forward delivery entered into in connection with protection against fluctuation in currency rates or prices where the exposure arises in the ordinary course of business or in respect of payments to be made under the Terms and Conditions, but not any transaction for investment or speculative purposes;
(f) arising under any interest rate hedging transactions in respect of payments to be made under the Terms and Conditions, but not any transaction for investment or speculative purposes;
(g) related to any Shareholder Loans;
(h) related to the Vendor Loan;
(i) incurred under Advance Purchase Agreements, including the Customs Loan;
(j) incurred as a result of any Group Company acquiring another entity, save for the Target Company, and which is due to that such acquired entity holds indebtedness, provided that the Incurrence Test is met, tested pro forma including the acquired entity in question and provided that the acquired debt is refinanced by the Issuer, by way of Subsequent Bonds or otherwise, within six (6) months following the date of acquisition;
(k) incurred by the Issuer if such Financial Indebtedness meets the Incurrence Test tested pro forma including such incurrence, and (i) is incurred as a result of a Subsequent Bond Issue by the Issuer under the Terms and Conditions, or (ii) ranks pari passu or is subordinated to the obligations of the Issuer under the Finance Documents, and has a final maturity date or a final redemption date or, when applicable, early redemption dates or instalment dates which occur after the Final Redemption Date;
(l) pension liabilities of the Group;
(m) until the Completion Date, any Refinancing Debt;
